Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510655, China
NCT Number: NCT06936098
Colorectal cancer (CRC) is a leading cause of mortality in China, with metastasis significantly contributing to poor outcomes. Histopathological growth patterns (HGPs) in colorectal liver metastasis (CRLM) provide vital prognostic insights, yet the limited number of pathologists highlights the need for auxiliary diagnostic tools. Recent advancements in artificial intelligence (AI) have demonstrated potential in enhancing diagnostic precision, prompting the development of specialized AI models like COFFEE to improve the classification and management of HGPs in CRLM patients. This study aims to develop and validate a Transformer-based deep learning model, COFFEE, for the classification of colorectal cancer subtypes using whole slide images (WSIs) from patients diagnosed with colorectal cancer liver metastasis. The model is pre-trained using self-supervised learning (DINO) on WSIs from the TCGA-COAD cohort, utilizing a Vision Transformer (ViT) architecture to extract 384-dimensional feature vectors from 256×256 pixel patches. The COFFEE model integrates a Transformer-based Multiple Instance Learning (TransMIL) framework, incorporating multi-head self-attention and Pyramid Position Encoding Generator (PPEG) modules to aggregate spatial and morphological information. The study includes training, testing, and prospective validation cohorts and evaluates the performance of the model in both binary and multi-class classification settings, as well as its potential to assist pathologists in clinical workflows.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Guangzhou, Guangdong, 510655, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical resection of colorectal cancer liver metastasis (CRLM) involves the removal of metastatic lesions from the liver. This procedure is aimed at improving survival rates and reducing tumor burden in patients diagnosed with CRLM. The resection is performed to treat liver metastasis, and clinical outcomes, such as progression-free survival (PFS) and overall survival (OS), are assessed post-surgery to determine treatment efficacy.
Time frame: 6 months post-surgery (for prospective cohort)
This outcome measures the diagnostic classification accuracy of the COFFEE AI model in detecting histopathological growth patterns (HGPs) in patients with colorectal cancer liver metastasis (CRLM). Accuracy is defined as the proportion of correctly predicted HGP labels compared to the ground truth labels determined by consensus of expert pathologists. The analysis includes binary classification (desmoplastic vs. non-desmoplastic). Accuracy will be calculated as: Accuracy = Total number of predictions / Number of correct predictions×100%. The outcome will be assessed using digital whole slide images obtained from liver metastasis specimens collected during surgery. Model performance will be evaluated 6 months post-surgery in a prospective validation cohort.
Time frame: 6 months post-surgery (for prospective cohort)
This outcome measures the diagnostic classification accuracy of the COFFEE AI model in detecting histopathological growth patterns (HGPs) in patients with colorectal cancer liver metastasis (CRLM). Accuracy is defined as the proportion of correctly predicted HGP labels compared to the ground truth labels determined by consensus of expert pathologists. The analysis includes four-class classification (desmoplastic, replacement, pushing, and mixed). Accuracy will be calculated as: Accuracy = Total number of predictions / Number of correct predictions×100%. The outcome will be assessed using digital whole slide images obtained from liver metastasis specimens collected during surgery. Model performance will be evaluated 6 months post-surgery in a prospective validation cohort.
Time frame: Up to 3 years post-surgery
This outcome evaluates the association between AI-based HGP classification (desmoplastic and non-desmoplastic) and progression-free survival (PFS) in patients with colorectal cancer liver metastasis (CRLM) following curative-intent resection. PFS is defined as the time from surgery to disease progression or death from any cause. Kaplan-Meier analysis will be used to estimate PFS for each HGP group, with comparisons by log-rank test. Multivariate Cox regression models will assess the prognostic value of HGPs, adjusting for clinical covariates (e.g., age, sex, metastasis number/size, chemotherapy, margin status, tumor burden score). Hazard ratios with 95% confidence intervals will be reported. Model assumptions will be tested and adjusted if necessary.
Time frame: Up to 3 years post-surgery
This outcome evaluates the association between AI-based HGP classification (desmoplastic and non-desmoplastic) and overall survival (OS) in patients with colorectal cancer liver metastasis (CRLM) following curative-intent resection. OS is defined as the time from surgery to death from any cause. Kaplan-Meier analysis will be used to estimate OS for each HGP group, with comparisons by log-rank test. Multivariate Cox regression models will assess the prognostic value of HGPs, adjusting for clinical covariates (e.g., age, sex, metastasis number/size, chemotherapy, margin status, tumor burden score). Hazard ratios with 95% confidence intervals will be reported. Model assumptions will be tested and adjusted if necessary.
Time frame: During the prospective trial period (6 months)
This outcome assesses the impact of the AI-assisted COFFEE model on diagnostic efficiency by comparing the time required by pathologists to classify histopathological growth patterns (HGPs) of colorectal cancer liver metastasis (CRLM), with and without COFFEE assistance. The metric is the time (minutes) from slide review start to final diagnosis, measured for each pathologist using a standardized digital whole slide image platform. The comparison includes two arms: the AI-assisted diagnosis arm, where junior pathologists use COFFEE as a decision-support tool, and the conventional diagnosis arm, where pathologists perform manual classification based on visual histopathological assessment. All participants review the same set of slides in randomized order, and diagnostic time is logged by the viewing software. Descriptive statistics (median, IQR) will be reported.
Time frame: During the prospective trial period (6 months)
This outcome evaluates the diagnostic accuracy of pathologists in classifying histopathological growth patterns (HGPs) of colorectal cancer liver metastasis (CRLM), comparing AI-assisted versus conventional diagnostic workflows. Accuracy is defined as the proportion of correctly classified whole slide images (WSIs) relative to a gold-standard consensus diagnosis by expert gastrointestinal pathologists. Each pathologist will independently classify the same set of CRLM WSIs under two conditions: with AI assistance (COFFEE model) and without AI assistance (manual assessment). Classification will be evaluated for both binary HGP categories (desmoplastic vs. non-desmoplastic) and four-class HGP categories (desmoplastic, replacement, pushing, mixed). Accuracy will be calculated as: Accuracy = Total number of predictions / Number of correct predictions×100%.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Other
AI-Powered Copilots for Precision Diagnosis and Surgical Assessment of Histological Growth Patterns in Resectable Colorectal Liver Metastases: A Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07559851
Colorectal Liver Metastasis (CRLM)
Changchun, Jilin, China
View Trial DetailsNCT07385521
Colorectal Liver Metastasis (CRLM), Hepatectomy
Milan, Italy
View Trial DetailsNCT07321847
Colon Cancer Liver Metastases, Colonic Diseases
View Trial DetailsNCT07310537
Circulating Tumor DNA (ctDNA), Colonic Diseases
Rotterdam, South Holland, Netherlands
View Trial Details